SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-019554
Filing Date
2022-10-13
Accepted
2022-10-13 17:17:51
Documents
16
Period of Report
2022-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sabs-20221011.htm   iXBRL 8-K 64273
2 EX-10.1 sabs-ex10_1.htm EX-10.1 165848
3 GRAPHIC img83562661_0.jpg GRAPHIC 135130
4 GRAPHIC img83562661_1.jpg GRAPHIC 58693
  Complete submission text file 0000950170-22-019554.txt   668210

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sabs-20221011_def.xml EX-101.DEF 13467
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sabs-20221011_lab.xml EX-101.LAB 17250
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sabs-20221011.xsd EX-101.SCH 3214
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sabs-20221011_pre.xml EX-101.PRE 12759
10 EXTRACTED XBRL INSTANCE DOCUMENT sabs-20221011_htm.xml XML 6479
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39871 | Film No.: 221309690
SIC: 2836 Biological Products, (No Diagnostic Substances)